Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
451.10    1.10 (0.24%)
Bid:
450.60
Ask:
450.70
Spread: 0.10 (0.022%)
Market Cap: £11.35b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Directorate Change

28 Feb 2008 07:02

Rentokil Initial PLC28 February 2008 28 February 2008 Rentokil Initial plc: Board Announcement Rentokil Initial today announces that after eleven years as a director andalmost four years as chairman, Brian McGowan has decided to step down from theboard no later than this year's AGM on 14 May 2008. A process has alreadystarted to find a new chairman with the right credentials. Doug Flynn, chief executive of Rentokil Initial, said: "Brian's decisive action and strong leadership have been of immense value to theboard, the company and its shareholders over the last eleven years. He has neverbeen slow to take difficult decisions, demonstrated most notably by hiswillingness to step up to the mark and take on the role of executive chairman in2004. More recently, as non-executive chairman, my board colleagues and I havevalued his advice and experience through what has been a challenging period. Wewill all miss him." Brian McGowan, chairman, Rentokil Initial, said: "Rentokil Initial is a world class business with strong brands and powerfulcapabilities. The last few years have been challenging but Doug and the team cannow point to a demonstrable operational turnaround in the vast majority of thegroup's businesses. I have enjoyed my time with the group but have decided thatthe time has come for the board to look for a new chairman to help guideRentokil Initial through the next stage in its development." Media enquiries: Malcolm Padley Rentokil Initial plc 07788 978199 Kate Holgate/Tom Williams Brunswick Group 020 7404 5959 Notes for Editors: Brian McGowan Brian McGowan was appointed a non-executive director of Rentokil Initial inOctober 1996. He was appointed non-executive chairman in May 2004 and served asexecutive chairman of the board between July 2004 and February 2005. Brian isalso chairman of UMECO plc and Catalyst Corporate Finance LLP. He previouslyserved as chief executive of Williams plc and chairman of House of Fraser Plc. Rentokil Initial Rentokil Initial is one of the largest business services companies in the world,operating in all the major economies of Europe, North America, Asia Pacific andAfrica. The company provides a wide range of support services in over 49countries and employs over 79,000 people. Services include textiles and washroomservices, pest control, interior plants and artwork, parcels delivery andfacilities services. For further information visit: www.rentokil-initial.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
29th Aug 20187:00 amRNSDirector/PDMR Shareholding
20th Aug 201812:44 pmRNSDirector/PDMR Shareholding
1st Aug 20183:12 pmRNSHolding(s) in Company
31st Jul 20187:00 amRNSInterim Results
27th Jul 20185:07 pmRNSHolding(s) in Company
5th Jul 20184:52 pmRNSHolding(s) in Company
5th Jul 201811:36 amRNSDirector Declaration
28th Jun 20184:10 pmRNSHolding(s) in Company
7th Jun 20185:16 pmRNSDirector Declaration
17th May 20184:12 pmRNSDirector/PDMR Shareholding
16th May 20187:00 amRNSNotice of Capital Markets Days
9th May 20185:40 pmRNSResult of AGM
4th May 20184:27 pmRNSDirector/PDMR Shareholding
2nd May 201810:52 amRNSDirector/PDMR Shareholding
1st May 20186:00 pmRNSDirector/PDMR Shareholding
30th Apr 20185:48 pmRNSDirector/PDMR Shareholding
26th Apr 20183:24 pmRNSHolding(s) in Company
25th Apr 20184:50 pmRNSHolding(s) in Company
24th Apr 20183:55 pmRNSHolding(s) in Company
24th Apr 201810:53 amRNSHolding(s) in Company
20th Apr 20184:09 pmRNSDirector/PDMR Shareholding
19th Apr 20184:32 pmRNSHolding(s) in Company
19th Apr 20187:00 amRNSQ1 Trading Update
5th Apr 201812:57 pmRNSHolding(s) in Company
5th Apr 201811:06 amRNSAnnual Financial Report
4th Apr 20186:01 pmRNSDirector/PDMR Shareholding
3rd Apr 20184:12 pmRNSBlock listing Interim Review
29th Mar 201811:55 amRNSTotal Voting Rights
27th Mar 20184:01 pmRNSHolding(s) in Company
27th Mar 201812:58 pmRNSAdditional Listing
8th Mar 20185:50 pmRNSDirector/PDMR Shareholding
1st Mar 20187:00 amRNSFinal Results
27th Dec 20177:00 amRNSDirector/PDMR Shareholding
20th Dec 20173:40 pmRNSDirector/PDMR Shareholding
22nd Nov 20174:30 pmRNSHolding(s) in Company
17th Nov 20177:00 amRNSIssue of new EUR400m bond
13th Nov 20174:35 pmRNSHolding(s) in Company
13th Nov 20177:00 amRNSPurchase of Vector Disease Acquisition LLC
7th Nov 20174:14 pmRNSHolding(s) in Company
6th Nov 20177:00 amRNSDirectorate Change
2nd Nov 20176:07 pmRNSHolding(s) in Company
1st Nov 20177:00 amRNSDirectorate Change
19th Oct 20177:00 amRNSQ3 Trading Update
2nd Oct 20173:26 pmRNSBlock listing Interim Review
21st Sep 20177:00 amRNSDirectorate Change
18th Sep 20177:00 amRNSDirectorate Change
22nd Aug 20173:34 pmRNSChange to Director's details
4th Aug 201711:57 amRNSDirector/PDMR Shareholding
31st Jul 20172:16 pmRNSDirector Declaration
27th Jul 20177:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.